Detalhe da pesquisa
1.
Tiotropium add-on therapy is safe and reduces seasonal worsening in paediatric asthma patients.
Eur Respir J
; 53(6)2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31097514
2.
Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV1.
Respir Res
; 20(1): 159, 2019 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31319851
3.
A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma.
J Allergy Clin Immunol
; 140(5): 1277-1287, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28189771
4.
A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma.
Eur Respir J
; 49(1)2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27811070
5.
Pharmacokinetics of tiotropium administered by Respimat® in asthma patients: Analysis of pooled data from Phase II and III clinical trials.
Pulm Pharmacol Ther
; 42: 25-32, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28039077
6.
Tiotropium add-on therapy in adolescents with moderate asthma: A 1-year randomized controlled trial.
J Allergy Clin Immunol
; 138(2): 441-450.e8, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26960245
7.
Magnitude of effect of asthma treatments on Asthma Quality of Life Questionnaire and Asthma Control Questionnaire scores: Systematic review and network meta-analysis.
J Allergy Clin Immunol
; 136(4): 914-22, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25936565
8.
Tiotropium in asthma poorly controlled with standard combination therapy.
N Engl J Med
; 367(13): 1198-207, 2012 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22938706
9.
A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.
Respir Res
; 16: 20, 2015 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25851298
10.
Tiotropium Respimat® in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma.
Respir Res
; 15: 61, 2014 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24890738
11.
Pooled analysis of tiotropium Respimat(®) pharmacokinetics in cystic fibrosis.
Pulm Pharmacol Ther
; 29(2): 217-23, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25161072
12.
Pharmacokinetics of tiotropium in asthmatic children aged 6-11 years support its safety profile.
Pediatr Allergy Immunol
; 29(7): 773-776, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29972697
13.
Efficacy of tiotropium in adults with moderate asthma, by leukotriene receptor antagonist use at baseline.
Allergol Int
; 67(3): 411-413, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29398589
14.
Salivette® Cortisol versus oropharyngeal swabbing for the detection of SARS-CoV-2 infection.
Expert Rev Mol Diagn
; 23(11): 1011-1014, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37724431
15.
Pilot study of an occupational healthcare program to assess the SARS-CoV-2 infection and immune status of employees in a large pharmaceutical company.
Curr Med Res Opin
; 37(6): 939-947, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33836626
16.
Erratum to: A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.
Respir Res
; 16: 128, 2015 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26487277
17.
Tiotropium Respimat Efficacy and Safety in Asthma: Relationship to Age.
J Allergy Clin Immunol Pract
; 8(8): 2653-2660.e4, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32320797
18.
Forced Expiratory Flow (FEF25-75%) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis.
Pulm Ther
; 6(2): 151-158, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32399899
19.
Comparative Responses in Lung Function Measurements with Tiotropium in Adolescents and Adults, and Across Asthma Severities: A Post Hoc Analysis.
Pulm Ther
; 6(1): 131-140, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32180164
20.
Tiotropium Respimat Add-on Is Efficacious in Symptomatic Asthma, Independent of T2 Phenotype.
J Allergy Clin Immunol Pract
; 6(3): 923-935.e9, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29174062